FNY Investment Advisers’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,000
| Closed | -$28K | – | 759 |
|
|
2022
Q1 | $28K | Buy |
8,000
+3,000
| +60% | +$10.5K | 0.03% | 317 |
|
|
2021
Q4 | $19K | Sell |
5,000
-13,025
| -72% | -$49.5K | 0.01% | 318 |
|
|
2021
Q3 | $118K | Buy |
18,025
+2,000
| +12% | +$13.1K | 0.05% | 203 |
|
|
2021
Q2 | $98K | Sell |
16,025
-13,091
| -45% | -$80.1K | 0.04% | 285 |
|
|
2021
Q1 | $131K | Buy |
29,116
+1,016
| +4% | +$4.57K | 0.05% | 257 |
|
|
2020
Q4 | $168K | Buy |
28,100
+6,100
| +28% | +$36.5K | 0.05% | 215 |
|
|
2020
Q3 | $163K | Buy |
22,000
+12,000
| +120% | +$88.9K | 0.07% | 179 |
|
|
2020
Q2 | $40K | Buy |
+10,000
| New | +$40K | 0.02% | 213 |
|